Get started
Author

Yue Ren

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
2021 · Joseph M. Gozgit, Melissa M. Vasbinder, et al. · Cancer Cell · 191
Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
2018 · Sheila K. Pierson, Aaron J. Stonestrom, et al. · American Journal of Hematology · 95
PDF
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants
2021 · Laurie B. Schenkel, Jennifer R. Molina, et al. · Cell chemical biology · 73
PDF
Proteomics of CKD progression in the chronic renal insufficiency cohort
2023 · Ruth F. Dubin, Rajat Deo, et al. · Nature Communications · 71
PDF
Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B
2023 · Penglei Jiang, Hongyu Jia, et al. · Hepatology · 57
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation
2019 · Alvin Z. Lu, Ryan Abo, et al. · Biochemical Pharmacology · 50
PDF
In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement
2020 · Tim J. Wigle, Danielle J. Blackwell, et al. · Cell chemical biology · 23
PDF
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease
2024 · Mateo Sarmiento Bustamante, Sheila K. Pierson, et al. · Haematologica · 19
PDF
Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule
2021 · Tim J. Wigle, Yue Ren, et al. · ChemBioChem · 18
Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
2021 · Jian Ma, Bowen Xing, et al. · EMBO Molecular Medicine · 18
PDF
Identifying Genomic Variations in Monozygotic Twins Discordant for Autism Spectrum Disorder Using Whole-Genome Sequencing
2018 · Yan Huang, Yue Zhao, et al. · Molecular Therapy — Nucleic Acids · 15
PDF
Abstract DDT02-01: RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways
2020 · Melissa M. Vasbinder, Joseph M. Gozgit, et al. · Cancer Research · 7
Inhibition of andrographolide in RAW 264.7 murine macrophage osteoclastogenesis by downregulating the nuclear factor-kappaB signaling pathway
2015 · Y.Q. Ren, Y.B. Zhou · Genetics and Molecular Research · 6
PDF
Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain
2019 · Sheila K Pierson, Yue Ren, et al. · Blood · 5
[Associations between vitamin D levels and systemic lupus erythematosus risk:a Mendelian randomized study].
2023 · Y Q Ren, J P Liu, et al. · PubMed · 4
The PARP14 inhibitor RBN-3143 suppresses lung inflammation in preclinical models
2022 · M Niepel, M Vasbinder, et al. · European Respiratory Journal · 4
Abstract 1344: Small molecule inhibitor of CD38 modulates its intra- and extracellular functions leading to antitumor activity
2021 · Prashant Shambharkar, Danielle J. Blackwell, et al. · Cancer Research · 4
Linking Chronic Kidney Disease to Incident Heart Failure and Adverse Cardiac Remodeling Through the Plasma Proteome
2025 · Leo F. Buckley, Pranav Dorbala, et al. · JACC Heart Failure · 3
Abstract 2154: PARP7 inhibitor RBN-2397 increases tumoral IFN signaling leading to various tumor cell intrinsic effects and tumor regressions in mouse models
2022 · Jennifer R. Molina, Joseph M. Gozgit, et al. · Cancer Research · 3
Relationship Between Timing of Hemodialysis and Procedure-Related Complications Following Endoscopy in Patients with End-Stage Renal Disease
2025 · Hansol Kang, Basavana Goudra, et al. · Digestive Diseases and Sciences · 2
PDF
Greater Fatigue and Reduced Neurocognitive Speed With Symptomatic Crohn’s Disease
2024 · Brittaney Bonhomme, Neilanjan Nandi, et al. · Crohn s & Colitis 360 · 2
PDF
Increased Comorbidities and Hospitalizations Associated with Idiopathic Multicentric Castleman Disease
2022 · Mateo Sarmiento Bustamante, Sheila K Pierson, et al. · Blood · 2
Abstract 48: RBN-2397: A potent and selective small molecule inhibitor of PARP7 that induces tumor-derived antitumor immunity dependent on CD8 T cells
2021 · Joseph M. Gozgit, Melissa M. Vasbinder, et al. · Cancer Research · 2
Rationally Engineered Coronavirus-mimicking Protein Nanocage Platform for Glioblastoma Targeted Delivery and Immunity Regulation
2025 · Jiaqi Li, Jian Feng, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Castleman disease spectrum.
2020 · Johnson Khor, Sheila K. Pierson, et al. · Journal of Clinical Oncology · 1
Works count: 34
Citation count: 677
H-index: 11
I10-index: 11
Year
Topic
Type